BUSINESS● LOWAug 14 · Aug 14, 2026, 10:55 AM
CASI Pharmaceuticals GAAP EPS of -$0.97, revenue of $9.8M
Seeking Alpha Tech
CASI Pharmaceuticals has reported its GAAP EPS of -$0.97 and revenue of $9.8 million. This is a routine financial performance update for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS44m agoGold market consolidating rather than entering bear market, Metals Focus analyst saysSeeking Alpha TechBUSINESS45m agoCollegium resolves Nucynta patent dispute with GrünenthalSeeking Alpha Tech